How much has Primmune Therapeutics raised?
$63.2Macross 5 recorded rounds · Oct 2017 – Oct 2020
Most recently, Primmune Therapeutics raised $13.0M in its Early Stage VC (Oct 2020).
Free account
More of Primmune Therapeutics with a free account
- ·Watch Primmune Therapeutics: the Monday email on marks, rounds and moves
Primmune Therapeutics round by round
5 rounds12 investors participated
2 investors participated
17 investors participated
19 investors participated
36 investors participated
How much has Primmune Therapeutics raised?
Primmune Therapeutics has raised $63.2 million in total; 5 of its rounds are on record, from 2017 on. The largest on record was a $2.5 million seed round in Feb 2020; the most recent was a $13 million early-stage round in Oct 2020.
Primmune Therapeutics has filed 6 Form Ds with the SEC since 2017, most recently in Nov 2020 ($13 million sold to 12 investors).
Primmune Therapeutics investors
9 investors are on record for Primmune Therapeutics, including Johnson & Johnson Innovation - JLABS, Polaris Partners, Samsara BioCapital and CAM Capital. The early-stage round in Oct 2020 drew 12 investors.
For fundraisers
Raising for a company like Primmune Therapeutics?
9 investors have backed Primmune Therapeutics.
Frequently asked about Primmune Therapeutics
- How much has Primmune Therapeutics raised?
- Primmune Therapeutics has raised $63.2M in total across 5 recorded funding rounds.
- When was Primmune Therapeutics's last funding round?
- Primmune Therapeutics's most recent recorded round was Early Stage VC in Oct 2020, raising $13.0M.